5-PHENYL-6-PYRIDIN-4-YL-1,3-DIHYDRO-2H-IMIDAZO[4,5-b]PYRIDIN-2-ONE DERIVATIVES USEFUL AS A2B ADENOSINE RECEPTOR ANTAGONISTS
申请人:Aiguade Bosch Jose
公开号:US20100105723A1
公开(公告)日:2010-04-29
The present disclosure relates to compounds of formula (I):
or a pharmaceutically acceptable salt or N-oxide thereof.
The present disclosure also relates to pharmaceutical compositions comprising the compounds of formula (I), and to their methods of treatment.
5-PHENYL-6-PYRIDIN-4-YL-1,3-DIHYDRO-2H-IMIDAZO[4,5-B]PYRIDIN-2-ONE DERIVATIVES USEFUL AS A2B ADENOSINE RECEPTOR ANTAGONISTS
申请人:Almirall, S.A.
公开号:EP2125804B1
公开(公告)日:2011-01-26
5-PHENYL-6-PYRIDIN-4-YL-1,3-DIHYDRO-2H-IMIDAZOÝ4,5-B¨PYRIDIN-2-ONE DERIVATIVES USEFUL AS A2B ADENOSINE RECEPTOR ANTAGONISTS
申请人:Almirall, S.A.
公开号:EP2125804A1
公开(公告)日:2009-12-02
[EN] 5-PHENYL-6-PYRIDIN-4-YL-1,3-DIHYDRO-2H-IMIDAZO[4,5-B]PYRIDIN-2-ONE DERIVATIVES USEFUL AS A2B ADENOSINE RECEPTOR ANTAGONISTS<br/>[FR] DÉRIVÉS DE 5-PHÉNYL-6-PYRIDIN-4-YL-1,3-DIHYDRO-2H-IMIDAZO[4,5-B]PYRIDIN-2-ONE UTILISABLES EN TANT QU'ANTAGONISTES DU RÉCEPTEUR A2B DE L'ADÉNOSINE
申请人:ALMIRALL LAB
公开号:WO2008080461A1
公开(公告)日:2008-07-10
[EN] A compound of formula (I) wherein: G1 is selected from the groups consisting of fluorine and chlorine atoms, G2 is selected from the groups consisting of hydrogen, fluorine and chlorine atoms, and G3 is selected from the groups consisting of fluorine and chlorine atoms and pharmaceutically acceptable salts or N-oxides thereof. [FR] La présente invention concerne un composé de formule (I) dans laquelle : G1 est choisi dans les groupes consistant en atomes de fluor et de chlore, G2 est choisi dans les groupes consistant en atomes d'hydrogène, de fluor et de chlore et G3 est choisi dans les groupes consistant en atomes de fluor et de chlore, et les sels ou les N-oxydes pharmaceutiquement acceptables de celui-ci.